Acta Scientific Neurology (ASNE) (ISSN: 2582-1121)

Research Article Volume 5 Issue 5

Small Fiber Neuropathy and Intrathecal Presence of IgG Oligoclonal Bands Post- Vaccination with Oxford-AstraZeneca Covid-19 Vaccine

Anthoula Tsolaki1*, Efstratios Vakilrlis2, Mattheos Bobos3, Dimitrios Hatzibougias4, Charikleia Kouvidou5, Andreas Markou6, Antonis Frontistis1, Thomas Tegos1 and Magda Tsolaki7

11stDepartment of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
2Department of Dermatology and Venereology, Aristotle University of Thessaloniki, Greece
3Department of Biomedical Sciences, School of Health Sciences, International Hellenic University, Alexandrian Campus, Sindos, Thessaloniki, Greece
4Private Pathology Laboratory, ''Microdiagnostics'', Thessaloniki, Greece
5Pathology Department, Evangelismos General Hospital, Athens, Greece
6Radiology Department, Public Health Centre of Ptolemaida, Greece
7Alzheimer Hellas, Greece

*Corresponding Author: Anthoula Tsolaki, 1stDepartment of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Received: March 22, 2022; Published: April 22, 2022



Since the COVID-19 pandemic outbreak, the development of vaccines for passive immunization against SARS-CoV-2 has been a great scientific achievement. However, all these vaccines have been rarely related to neurological adverse events. We present an extremely rare case of a 39-year-old healthy male adult who developed an immune-mediated adverse event of a small fiber neuropathy and radiculopathy post-anti-COVID vaccination with Oxford-Astra Zeneca Covid-19 vaccine. Despite this rare adverse event, we underline that both at an individual and a population level, the benefits of COVID-19 vaccination far outweigh the risks of a neurological complication.

Keywords: Small Fiber; Neuropathy; Covid-19; Intrathecal



  1. Waheed W., et al. “Post COVID-19 vaccine small fiber neuropathy”. Muscle Nerve1 (2021): E1-E2.
  2. Goss AL., et al. “ANA Investigates: Neurological Complications of COVID-19 Vaccines”. Annals of Neurology 89 (2021): 856-857.
  3. Kim DD., et al. “Helping the Public Understand Adverse Events Associated with COVID-19 Vaccinations: Lessons Learned from Functional Neurological Disorder”. JAMA Neurology 7 (2021): 789-790.
  4. Devigili G., et al. “Clinical diagnosis and management of small fiber neuropathy: an update on best practice”. Expert Review of Neurotherapeutics 9 (2020): 967-980.
  5. Raasing LRM., et al. “Current View of Diagnosing Small Fiber Neuropathy”. Journal of Neuromuscular Diseases2 (2021): 185-207.
  6. Vecchio M., et al. “A systematic review of pharmacologic and rehabilitative treatment of small fiber neuropathies”. Diagnostics12 (2020).
  7. Souayah N., et al. “Small fiber neuropathy following vaccination for rabies, varicella or Lyme disease”. Vaccine52 (2009): 7322-7325.
  8. Liu X., et al. “IVIg for apparently autoimmune small-fiber polyneuropathy: First analysis of efficacy and safety”. Therapeutic Advances in Neurological Disorders 11 (2018): 1-12.
  9. Watad A., et al. “Immune-mediated disease flares or new-onset disease in 27 subjects following mrna/dna sars-cov-2 vaccination”. Vaccines5 (2021): 1-23.
  10. Lu L., et al. “The potential neurological effect of the COVID-19 vaccines: A review”. Acta Neurologica Scandinavica1 (2021): 3-12.
  11. Finsterer J and Scorza FA. SARS-CoV-2 vaccines are not free of neurological side effects”. Acta Neurologica Scandinavica 1 (2021): 109-110.
  12. Summary of Product Characteristics for Vaxzevria - GOV.UK (2021).
  13. Vaccine Adverse Event Reporting System (VAERS).
  14. Scheel DP. “Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19”. Annals of Oncology (2020): 19-20.
  15. Kow CS and Hasan SS. “Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies”. Inflammopharmacology 4 (2021): 1075.


Citation: Anthoula Tsolaki., et al. “Small Fiber Neuropathy and Intrathecal Presence of IgG Oligoclonal Bands Post- Vaccination with Oxford-AstraZeneca Covid-19 Vaccine". Acta Scientific Neurology 5.5 (2022): 20-25.


Acceptance rate32%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US